Skip to main content

Table 2 Mean MPR and persistence

From: Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

 

Control

Letter

Phone

Total

N = 51

N = 51

N = 53

N = 155

 

Mean

SD

Mean

SD

Mean

SD

Mean

SD

MPR (%)

70.4

31.8

79.7

27.9

78.4

26.5

76.2

28.9

Persistence (weeks)

38.6

17.5

44.7

16.8

42.8

14.8

42.1

16.5